SB 221284
chemical compound
≈ 2 min read
Names in other languages
- СрпскиSB-221,284
- EnglishSB 221284
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
SB-221284 is a selective serotonin 5-HT 2C and 5-HT 2B receptor antagonist which is used in scientific research. Its affinities (K i ) are 2.2 to 2.5 nM for the serotonin 5-HT 2C receptor, 2.5 to 12.6 nM for the serotonin 5-HT 2B receptor, and 398 to 550 nM for the serotonin 5-HT 2A receptor (where it is also an antagonist).
The drug has 160- to 250-fold selectivity for the serotonin 5-HT 2C receptor over the serotonin 5-HT 2A receptor. It is said to have been the first serotonin 5-HT 2C receptor ligand to show 100-fold selectivity over the serotonin 5-HT 2A receptor. SB-221284 has shown anxiolytic-like effects in animals.
Conversely, it has been said to be inactive in terms of antidepressant-like, antiobsessional-like, antipanic-like, and sedative effects. It also showed no proconvulsant or hyperphagic effects in animals, phenotypes that are notably observed with serotonin 5-HT 2C receptor knockout.
The preferential serotonin 5-HT 2C receptor agonist meta-chlorophenylpiperazine (mCPP) and the serotonin reuptake inhibitor fluoxetine have been found to acutely reduce social interaction in rodents. SB-221284 was found to reverse the acute decreases in social interaction produced by mCPP and fluoxetine. The drug has also been found to block mCPP-induced hypolocomotion.…
Text derived from https://en.wikipedia.org/w/index.php?oldid=1339586901 under CC BY-SA 4.0; modifications have been made.
References
21 claims could not be tied to a specific sentence and are listed in the table below instead.